1
|
Allen DZ, Aljabban J, Silverman D, McDermott S, Wanner RA, Rohr M, Hadley D, Panahiazar M. Meta-Analysis illustrates possible role of lipopolysaccharide (LPS)-induced tissue injury in nasopharyngeal carcinoma (NPC) pathogenesis. PLoS One 2021; 16:e0258187. [PMID: 34648530 PMCID: PMC8516236 DOI: 10.1371/journal.pone.0258187] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2020] [Accepted: 09/21/2021] [Indexed: 12/20/2022] Open
Abstract
Background Nasopharyngeal carcinoma (NPC) is a cancer of epithelial origin with a high incidence in certain populations. While NPC has a high remission rate with concomitant chemoradiation, recurrences are frequent, and the downstream morbidity of treatment is significant. Thus, it is imperative to find alternative therapies. Methods We employed a Search Tag Analyze Resource (STARGEO) platform to conduct a meta-analysis using the National Center for Biotechnology’s (NCBI) Gene Expression Omnibus (GEO) to define NPC pathogenesis. We identified 111 tumor samples and 43 healthy nasopharyngeal epithelium samples from NPC public patient data. We analyzed associated signatures in Ingenuity Pathway Analysis (IPA), restricting genes that showed statistical significance (p<0.05) and an absolute experimental log ratio greater than 0.15 between disease and control samples. Results Our meta-analysis identified activation of lipopolysaccharide (LPS)-induced tissue injury in NPC tissue. Additionally, interleukin-1 (IL-1) and SB203580 were the top upstream regulators. Tumorigenesis-related genes such as homeobox A10 (HOXA10) and prostaglandin-endoperoxide synthase 2 (PTGS2 or COX-2) as well as those associated with extracellular matrix degradation, such as matrix metalloproteinases 1 and 3 (MMP-1, MMP-3) were also upregulated. Decreased expression of genes that encode proteins associated with maintaining healthy nasal respiratory epithelium structural integrity, including sentan-cilia apical structure protein (SNTN) and lactotransferrin (LTF) was documented. Importantly, we found that etanercept inhibits targets upregulated in NPC and LPS induction, such as MMP-1, PTGS2, and possibly MMP-3. Conclusions Our analysis illustrates that nasal epithelial barrier dysregulation and maladaptive immune responses are key components of NPC pathogenesis along with LPS-induced tissue damage.
Collapse
Affiliation(s)
- David Z. Allen
- The Ohio State College of Medicine, Columbus, Ohio, United States of America
- * E-mail:
| | - Jihad Aljabban
- Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States of America
| | - Dustin Silverman
- Department of Otolaryngology, The Ohio State Wexner Medical Center, Columbus, Ohio, United States of America
| | - Sean McDermott
- The Ohio State College of Medicine, Columbus, Ohio, United States of America
| | - Ross A. Wanner
- The Ohio State College of Medicine, Columbus, Ohio, United States of America
| | - Michael Rohr
- University of Central Florida, Orlando, Florida, United States of America
| | - Dexter Hadley
- Department of Pathology, University of Central Florida, Orlando, Florida, United States of America
| | - Maryam Panahiazar
- Department of Surgery, University of California San Francisco, San Francisco, California, United States of America
| |
Collapse
|
2
|
Cui J, Yin Z, Liu G, Chen X, Gao X, Lu H, Li W, Lin D. Activating transcription factor 1 promoted migration and invasion in lung cancer cells through regulating EGFR and MMP-2. Mol Carcinog 2019; 58:1919-1924. [PMID: 31420907 DOI: 10.1002/mc.23086] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2019] [Revised: 06/26/2019] [Accepted: 07/04/2019] [Indexed: 12/28/2022]
Abstract
Lung cancer is among the most frequently occurring cancers and the leading cause of cancer-related deaths worldwide. Nonsmall cell lung cancer is accountable for 85% to 90% of all lung cancer cases and develops distant metastases with high mortality. In this work, we elucidated the role of activating transcription factor 1 (ATF1) in migration and invasion of lung cancer cells. We found that the migration and invasion were inhibited with ATF1 silencing in lung cancer cells. By contrast, ATF1 overexpression led to promotion in migration and invasion. The alteration in ATF1 expression induced a change in the epidermal growth factor receptor (EGFR) and matrix metalloproteinases (MMP)-2 expression level in the same tendency. Thus, we provided a potential new candidate for therapies against lung cancer, showing the possible mechanism underlying the invasion and migration of lung cancer cells.
Collapse
Affiliation(s)
- Jinggang Cui
- Department of Respiratory Medicine, Suzhou Municipal Hospital, Suzhou Hospital Affiliated Nanjing Medical University, Suzhou, Jiangsu, China
| | - Zhaofang Yin
- Department of General Medicine, Suzhou Municipal Hospital, Suzhou Hospital Affiliated Nanjing Medical University, Suzhou, Jiangsu, China
| | - Guohua Liu
- Department of Respiratory Medicine, Suzhou Municipal Hospital, Suzhou Hospital Affiliated Nanjing Medical University, Suzhou, Jiangsu, China
| | - Xiaojun Chen
- Department of Respiratory Medicine, Suzhou Municipal Hospital, Suzhou Hospital Affiliated Nanjing Medical University, Suzhou, Jiangsu, China
| | - Xiaolai Gao
- Department of Respiratory Medicine, Suzhou Municipal Hospital, Suzhou Hospital Affiliated Nanjing Medical University, Suzhou, Jiangsu, China
| | - Huiling Lu
- Department of Respiratory Medicine, Suzhou Municipal Hospital, Suzhou Hospital Affiliated Nanjing Medical University, Suzhou, Jiangsu, China
| | - Wei Li
- Department of Respiratory Medicine, Suzhou Municipal Hospital, Suzhou Hospital Affiliated Nanjing Medical University, Suzhou, Jiangsu, China
| | - Dang Lin
- Department of Respiratory Medicine, Suzhou Municipal Hospital, Suzhou Hospital Affiliated Nanjing Medical University, Suzhou, Jiangsu, China
| |
Collapse
|
3
|
Peng S, Huang GL, Xu N, Lu Y, Zeng L, Li X, Luo S, Lyu X, Jiang Q, Li T, He Z. The human ATF1 rs11169571 polymorphism associated with risk of nasopharyngeal carcinoma in Southern Chinese populations. Cancer Med 2019; 8:1893-1898. [PMID: 30905073 PMCID: PMC6488110 DOI: 10.1002/cam4.2022] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2018] [Revised: 01/08/2019] [Accepted: 01/16/2019] [Indexed: 12/12/2022] Open
Abstract
Our previous work reported activating transcription factor 1 (ATF1) is a promotive factor of nasopharyngeal carcinoma (NPC) tumorigenesis. This study is to further explore the association between the human ATF1 rs11169571 polymorphism and the risk of NPC occurrence. The association between ATF1 rs11169571 and risk of NPC occurrence was investigated in clinical samples of 560 patients and 661 controls obtained from southern China with high incidence of NPC. The genotypes were detected by PCR‐RFLP. The differential expression activity of alleles ‐T and ‐C was analyzed with CNE‐2 and C666‐1 cells by luciferase reporter assay. Our data suggested that the allelic frequency and genotypes were significantly different between patients and controls. Compared to the TT homozygote, the TC and CC genotypes have been shown to be significantly decreased in NPC patients (OR = 0.494, 95% CI = 0.387‐0.629, P < 0.001 and OR = 0.556, 95% CI = 0.364‐0.851, P = 0.007, respectively). Compared to the ‐T allele, the ‐C allele is a factor of decreased risk in NPC (OR = 0.642, 95% CI = 0.537‐0.767, P < 0.001). Luciferase reporter activity revealed that the ‐T allele confers a higher expression activity than the ‐C allele in CNE2 cells and C666‐1 cells. In conclusion, ATF1 rs11169571 which could affect the expression of ATF1 is associated with NPC risk.
Collapse
Affiliation(s)
- Shutang Peng
- China-American Cancer Research Institute, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan, China.,Key Laboratory for Epigenetics of Dongguan City, Dongguan, China.,Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China
| | - Guo-Liang Huang
- China-American Cancer Research Institute, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan, China.,Key Laboratory for Epigenetics of Dongguan City, Dongguan, China.,Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China
| | - Nansong Xu
- China-American Cancer Research Institute, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan, China.,Key Laboratory for Epigenetics of Dongguan City, Dongguan, China.,Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China
| | - Yan Lu
- China-American Cancer Research Institute, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan, China.,Key Laboratory for Epigenetics of Dongguan City, Dongguan, China.,Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China
| | - Liuyan Zeng
- Department of Health Management Center, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China
| | - Xin Li
- Cancer Research Institute, Southern Medical University, Guangzhou, China
| | - Shengqun Luo
- China-American Cancer Research Institute, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan, China.,Key Laboratory for Epigenetics of Dongguan City, Dongguan, China.,Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China
| | - Xiaoming Lyu
- Department of Laboratory Medicine, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
| | - Qiang Jiang
- Cancer Research Institute, Southern Medical University, Guangzhou, China
| | - Tong Li
- China-American Cancer Research Institute, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan, China.,Key Laboratory for Epigenetics of Dongguan City, Dongguan, China.,Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China
| | - Zhiwei He
- China-American Cancer Research Institute, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan, China.,Key Laboratory for Epigenetics of Dongguan City, Dongguan, China.,Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China
| |
Collapse
|